Perceptive Advisors as of March 31, 2017
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 169 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Neurocrine Biosciences (NBIX) | 8.4 | $146M | 3.4M | 43.30 | |
Global Blood Therapeutics In | 8.2 | $142M | 3.9M | 36.85 | |
Amicus Therapeutics (FOLD) | 7.1 | $123M | 17M | 7.13 | |
Versartis | 5.4 | $94M | 4.4M | 21.35 | |
La Jolla Pharmaceuticl Com Par | 3.7 | $64M | 2.1M | 29.85 | |
Alnylam Pharmaceuticals (ALNY) | 3.2 | $57M | 1.1M | 51.25 | |
Radius Health | 3.1 | $54M | 921k | 58.16 | |
Sarepta Therapeutics (SRPT) | 3.0 | $52M | 1.8M | 29.60 | |
Retrophin | 3.0 | $52M | 2.8M | 18.46 | |
NxStage Medical | 2.8 | $49M | 1.8M | 26.83 | |
Xencor (XNCR) | 2.2 | $38M | 1.6M | 23.92 | |
Aclaris Therapeutics (ACRS) | 2.2 | $38M | 1.3M | 29.82 | |
Tesaro | 2.1 | $37M | 241k | 153.87 | |
Vbi Vaccines | 2.1 | $36M | 6.6M | 5.49 | |
Avexis | 2.0 | $34M | 449k | 76.03 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.8 | $32M | 294k | 109.35 | |
Regenxbio Inc equity us cm (RGNX) | 1.6 | $27M | 1.4M | 19.30 | |
Lion Biotechnologies | 1.5 | $27M | 3.6M | 7.45 | |
Cytomx Therapeutics (CTMX) | 1.5 | $26M | 1.5M | 17.27 | |
Anaptysbio Inc Common (ANAB) | 1.4 | $25M | 882k | 27.75 | |
Ardelyx (ARDX) | 1.4 | $24M | 1.9M | 12.65 | |
Zogenix | 1.4 | $24M | 2.2M | 10.85 | |
Galapagos Nv- (GLPG) | 1.3 | $23M | 271k | 86.19 | |
Dbv Technologies S A (DBVT) | 1.2 | $21M | 592k | 35.22 | |
Quotient | 1.2 | $20M | 2.9M | 6.98 | |
Nevro (NVRO) | 1.2 | $20M | 217k | 93.70 | |
Kadmon Hldgs | 1.1 | $19M | 5.2M | 3.62 | |
Blueprint Medicines (BPMC) | 1.1 | $19M | 462k | 39.99 | |
Wave Life Sciences (WVE) | 1.1 | $18M | 665k | 27.50 | |
Acceleron Pharma | 1.0 | $18M | 664k | 26.47 | |
Acelrx Pharmaceuticals | 1.0 | $17M | 5.4M | 3.15 | |
Assembly Biosciences | 1.0 | $17M | 664k | 25.49 | |
Flamel Technologies Sa (AVDL) | 0.8 | $14M | 1.4M | 9.68 | |
Aldeyra Therapeutics (ALDX) | 0.7 | $13M | 2.9M | 4.47 | |
AMAG Pharmaceuticals | 0.7 | $13M | 560k | 22.55 | |
Biosante Pharmaceuticals (ANIP) | 0.7 | $13M | 255k | 49.51 | |
Corium Intl | 0.6 | $11M | 2.7M | 4.18 | |
Abiomed | 0.6 | $11M | 85k | 125.20 | |
Corbus Pharmaceuticals Hldgs | 0.6 | $10M | 1.3M | 8.25 | |
Clovis Oncology | 0.6 | $10M | 158k | 63.67 | |
Irhythm Technologies (IRTC) | 0.6 | $10M | 271k | 37.60 | |
Bio-Rad Laboratories (BIO) | 0.6 | $9.9M | 49k | 199.35 | |
EXACT Sciences Corporation (EXAS) | 0.6 | $9.7M | 410k | 23.62 | |
Antares Pharma | 0.5 | $8.3M | 2.9M | 2.84 | |
Myokardia | 0.5 | $8.2M | 625k | 13.15 | |
Capital Senior Living Corporation | 0.5 | $8.1M | 575k | 14.06 | |
Alder Biopharmaceuticals | 0.5 | $8.0M | 384k | 20.80 | |
Ani Pharmaceuticals Inc. note 3.000 12/0 | 0.5 | $8.0M | 7.5M | 1.06 | |
Forward Pharma A/s | 0.4 | $7.6M | 354k | 21.55 | |
Uniqure Nv (QURE) | 0.4 | $7.3M | 1.3M | 5.78 | |
Minerva Neurosciences | 0.4 | $6.6M | 811k | 8.10 | |
Foamix Pharmaceuticals | 0.4 | $6.5M | 1.3M | 4.95 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.4 | $6.4M | 826k | 7.80 | |
Viveve Med | 0.3 | $5.9M | 939k | 6.33 | |
Humana (HUM) | 0.3 | $5.7M | 28k | 206.15 | |
Evolent Health (EVH) | 0.3 | $5.7M | 1.5M | 3.80 | |
Clearside Biomedical (CLSD) | 0.3 | $5.7M | 712k | 7.94 | |
Sierra Oncology | 0.3 | $5.7M | 3.7M | 1.53 | |
Pfenex | 0.3 | $5.2M | 893k | 5.81 | |
Invitae (NVTAQ) | 0.3 | $5.3M | 480k | 11.06 | |
Zynerba Pharmaceuticals | 0.3 | $5.1M | 251k | 20.10 | |
Neptune Technologies Bioreso | 0.3 | $4.6M | 6.5M | 0.71 | |
Synergy Pharmaceuticals | 0.3 | $4.6M | 978k | 4.66 | |
Jazz Pharmaceuticals (JAZZ) | 0.2 | $4.4M | 30k | 145.13 | |
Pphm 10 1/2 12/31/49 | 0.2 | $4.3M | 200k | 21.71 | |
Dermira | 0.2 | $3.9M | 116k | 34.11 | |
pSivida | 0.2 | $3.9M | 2.3M | 1.72 | |
Axovant Sciences | 0.2 | $3.6M | 510k | 7.10 | |
Abeona Therapeutics Inc *w exp 12/19/201 | 0.2 | $3.7M | 1.3M | 2.93 | |
Adma Biologics (ADMA) | 0.2 | $3.5M | 721k | 4.88 | |
Amgen (AMGN) | 0.2 | $3.3M | 20k | 164.05 | |
Histogenics Corp Cmn | 0.2 | $3.1M | 1.8M | 1.73 | |
Abeona Therapeutics | 0.2 | $3.1M | 623k | 5.00 | |
Oncobiologics | 0.2 | $3.2M | 1.2M | 2.68 | |
AVEO Pharmaceuticals | 0.2 | $3.0M | 5.1M | 0.59 | |
Xenon Pharmaceuticals (XENE) | 0.2 | $2.9M | 724k | 4.00 | |
Ocera Therapeutics | 0.2 | $2.8M | 2.2M | 1.31 | |
Mgc Diagnostics | 0.1 | $2.5M | 302k | 8.35 | |
Portola Pharmaceuticals | 0.1 | $2.3M | 58k | 39.19 | |
Aerie Pharmaceuticals | 0.1 | $2.3M | 50k | 45.36 | |
UnitedHealth (UNH) | 0.1 | $2.1M | 13k | 164.00 | |
Alliqua | 0.1 | $2.1M | 4.2M | 0.50 | |
Selecta Biosciences (RNAC) | 0.1 | $2.0M | 142k | 14.32 | |
Ra Pharmaceuticals | 0.1 | $2.1M | 100k | 21.29 | |
Immunomedics | 0.1 | $1.9M | 300k | 6.47 | |
Brainstorm Cell Therapeutics | 0.1 | $1.7M | 400k | 4.25 | |
Sage Therapeutics (SAGE) | 0.1 | $1.8M | 200k | 8.95 | |
Affimed Therapeutics B V | 0.1 | $1.7M | 734k | 2.30 | |
Eiger Biopharmaceuticals | 0.1 | $1.8M | 158k | 11.45 | |
Arrowhead Pharmaceuticals (ARWR) | 0.1 | $1.6M | 848k | 1.85 | |
Curis | 0.1 | $1.4M | 500k | 2.78 | |
Champions Oncology (CSBR) | 0.1 | $1.2M | 367k | 3.17 | |
Exelixis (EXEL) | 0.1 | $1.0M | 46k | 21.68 | |
Akorn | 0.1 | $963k | 40k | 24.08 | |
Bellicum Pharma | 0.1 | $1.1M | 86k | 12.34 | |
Zosano Pharma | 0.1 | $950k | 500k | 1.90 | |
Azurrx Biopharma | 0.1 | $877k | 227k | 3.86 | |
Incyte Corporation (INCY) | 0.0 | $751k | 5.6k | 133.65 | |
WellCare Health Plans | 0.0 | $741k | 5.3k | 140.26 | |
Heska Corporation | 0.0 | $661k | 6.3k | 104.92 | |
Fiat Chrysler Auto | 0.0 | $678k | 62k | 10.94 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.0 | $672k | 54k | 12.50 | |
Metastat | 0.0 | $660k | 500k | 1.32 | |
McKesson Corporation (MCK) | 0.0 | $534k | 3.6k | 148.29 | |
Illumina (ILMN) | 0.0 | $597k | 3.5k | 170.57 | |
Allscripts Healthcare Solutions (MDRX) | 0.0 | $545k | 43k | 12.69 | |
Hill-Rom Holdings | 0.0 | $560k | 7.9k | 70.62 | |
Vanda Pharmaceuticals (VNDA) | 0.0 | $507k | 36k | 13.99 | |
Centene Corporation (CNC) | 0.0 | $551k | 7.7k | 71.32 | |
HMS Holdings | 0.0 | $540k | 27k | 20.34 | |
Cambrex Corporation | 0.0 | $524k | 9.5k | 55.07 | |
Cutera (CUTR) | 0.0 | $496k | 24k | 20.68 | |
Quality Systems | 0.0 | $516k | 34k | 15.23 | |
OraSure Technologies (OSUR) | 0.0 | $609k | 47k | 12.92 | |
Masimo Corporation (MASI) | 0.0 | $554k | 5.9k | 93.19 | |
Achaogen | 0.0 | $593k | 24k | 25.24 | |
Akebia Therapeutics (AKBA) | 0.0 | $457k | 50k | 9.21 | |
Phibro Animal Health Corporati*on Cmn Class A (PAHC) | 0.0 | $517k | 18k | 28.13 | |
Anthem (ELV) | 0.0 | $510k | 3.1k | 165.53 | |
Proteon Therapeutics | 0.0 | $585k | 334k | 1.75 | |
Pra Health Sciences | 0.0 | $542k | 8.3k | 65.24 | |
Ferrari Nv Ord (RACE) | 0.0 | $461k | 6.2k | 74.35 | |
Bluebird Bio (BLUE) | 0.0 | $422k | 4.6k | 90.87 | |
Auris Med Hldg | 0.0 | $368k | 400k | 0.92 | |
Quorum Health | 0.0 | $275k | 51k | 5.43 | |
Oncobiologics Inc *w exp 02/18/201 | 0.0 | $370k | 463k | 0.80 | |
Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.0 | $280k | 1.0M | 0.28 | |
Array BioPharma | 0.0 | $228k | 26k | 8.94 | |
LHC | 0.0 | $256k | 4.7k | 53.95 | |
Arno Therapeutics | 0.0 | $251k | 4.2M | 0.06 | |
Acasti Pharma | 0.0 | $254k | 187k | 1.36 | |
Oncobiologics Inc *w exp 05/18/201 | 0.0 | $231k | 463k | 0.50 | |
Audentes Therapeutics | 0.0 | $128k | 7.5k | 17.07 | |
Abbott Laboratories (ABT) | 0.0 | $18k | 415.00 | 43.37 | |
BioMarin Pharmaceutical (BMRN) | 0.0 | $22k | 250.00 | 88.00 | |
Boston Scientific Corporation (BSX) | 0.0 | $0 | 3.00 | 0.00 | |
iShares S&P 500 Index (IVV) | 0.0 | $0 | 1.00 | 0.00 | |
Danaher Corporation (DHR) | 0.0 | $0 | 3.00 | 0.00 | |
China Biologic Products | 0.0 | $24k | 236.00 | 101.69 | |
West Pharmaceutical Services (WST) | 0.0 | $11k | 138.00 | 79.71 | |
CryoLife (AORT) | 0.0 | $2.0k | 123.00 | 16.26 | |
Cerus Corporation (CERS) | 0.0 | $3.0k | 740.00 | 4.05 | |
iShares Russell Midcap Value Index (IWS) | 0.0 | $0 | 2.00 | 0.00 | |
Peregrine Pharmaceuticals | 0.0 | $16k | 24k | 0.66 | |
Celldex Therapeutics | 0.0 | $25k | 7.0k | 3.59 | |
iShares Barclays 20+ Yr Treas.Bond (TLT) | 0.0 | $0 | 2.00 | 0.00 | |
AtriCure (ATRC) | 0.0 | $999.900000 | 55.00 | 18.18 | |
Credit Suisse Nassau Brh invrs vix sterm | 0.0 | $1.0k | 16.00 | 62.50 | |
Agenus (AGEN) | 0.0 | $14k | 3.6k | 3.89 | |
Acadia Healthcare (ACHC) | 0.0 | $0 | 1.00 | 0.00 | |
Tengion | 0.0 | $0 | 1.8M | 0.00 | |
Allon Therapeutics (NPCUF) | 0.0 | $0 | 751k | 0.00 | |
Abbvie (ABBV) | 0.0 | $25k | 380.00 | 65.79 | |
Epizyme | 0.0 | $20k | 1.2k | 17.17 | |
Therapeuticsmd | 0.0 | $8.0k | 1.1k | 7.40 | |
Alcobra | 0.0 | $10k | 9.1k | 1.10 | |
Ophthotech | 0.0 | $5.0k | 1.6k | 3.12 | |
Five Prime Therapeutics | 0.0 | $5.0k | 127.00 | 39.37 | |
Ignyta | 0.0 | $57k | 6.6k | 8.66 | |
Agile Therapeutics | 0.0 | $0 | 42.00 | 0.00 | |
Senesco Technologies | 0.0 | $8.9k | 59k | 0.15 | |
Tracon Pharmaceuticals | 0.0 | $0 | 50.00 | 0.00 | |
Capricor Therapeutics | 0.0 | $13k | 4.0k | 3.25 | |
Aeglea Biotherapeutics | 0.0 | $43k | 5.8k | 7.37 | |
Aptevo Therapeutics Inc apvo | 0.0 | $999.000000 | 450.00 | 2.22 | |
Aevi Genomic | 0.0 | $2.0k | 940.00 | 2.13 | |
Obalon Therapeutics | 0.0 | $0 | 4.00 | 0.00 | |
Cascadian Therapeutics | 0.0 | $8.0k | 2.0k | 4.07 | |
R1 Rcm | 0.0 | $56k | 18k | 3.12 |